TSH Biopharm Balance Sheet Health
Financial Health criteria checks 6/6
TSH Biopharm has a total shareholder equity of NT$1.3B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.4B and NT$133.6M respectively. TSH Biopharm's EBIT is NT$63.6M making its interest coverage ratio -5.1. It has cash and short-term investments of NT$772.1M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -5.1x |
| Cash | NT$772.12m |
| Equity | NT$1.27b |
| Total liabilities | NT$133.63m |
| Total assets | NT$1.40b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 8432's short term assets (NT$1.1B) exceed its short term liabilities (NT$133.6M).
Long Term Liabilities: 8432 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 8432 is debt free.
Reducing Debt: 8432 had no debt 5 years ago.
Debt Coverage: 8432 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 8432 has no debt, therefore coverage of interest payments is not a concern.